SCHEMBL14348341

SCHEMBL14348341

COc1ccc(-c2ccnc(Nc3ccccc3)n2)cc1NC(=O)COc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.61
PIK3CG P48736 4/20 0.55
CAMKK2 Q96RR4 4/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
TP53 P04637 2/20 0.53
PRKCA P17252 1/20 0.53
GAA P10253 1/20 0.53
MAPK8 P45983 3/20 0.52
JAK2 O60674 1/20 0.52
JAK3 P52333 1/20 0.52
GSK3B P49841 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8353979 0.92 CDK5 (0.58) MAPTPIK3CGCAMKK2L3MBTL1KDM4E
SCHEMBL5465150 0.84 HDAC1 (0.58) MAPTPIK3CGCAMKK2SMN1; SMN2GAA
SCHEMBL8352374 0.83 MAPT (0.57) MAPTL3MBTL1KDM4EALDH1A1HPGD
SCHEMBL14348340 0.83 MAPT (0.60) MAPTPIK3CGCAMKK2L3MBTL1KDM4E
SCHEMBL14253984 0.79 CAMK2D (0.61) PIK3CGCAMKK2PRKCAMAPK8JAK2
SCHEMBL14088787 0.78 JAK2 (0.59) PIK3CGCAMKK2PRKCAJAK2JAK3
SCHEMBL14253980 0.78 CAMK2D (0.57) PIK3CGCAMKK2PRKCAMAPK8JAK2
SCHEMBL5467323 0.78 GAA (0.60) MAPTPIK3CGKDM4EALDH1A1HPGD
SCHEMBL14253972 0.77 CAMKK2 (0.61) PIK3CGCAMKK2PRKCAMAPK8JAK2
SCHEMBL2938991 0.77 JAK2 (0.56) PIK3CGCAMKK2MAPK8JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed